
Interviews
“The biggest compliment I get is when people don’t notice my dog is here”
After seven years of service Tommy can take his retirement
READ MOREThe Michael J Fox Foundation is offering US$2 million to the first researcher to develop a tracer for alpha-synuclein – the protein that is a strong pathological indicator of Parkinson’s disease.
Imaging of alpha-synuclein could become a useful biomarker of the presence of the disease and possibly even a measure of disease progression.
In a statement issued on its website, the Foundation said: “The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson’s disease field.
“With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.”
The prize is open to all academic and industry researchers and contestants may already be funded by the MJFF or not. There is no deadline and the $2 million prize will be awarded to the first contestant who submits “compelling evidence of a viable selective tracer and agrees to its widespread use”.
To see the full submission requirements, the judging panel and how to apply, visit the website here
Learn more about alpha-synuclein in this free podcast: ‘Stopping disease progression’
After seven years of service Tommy can take his retirement
READ MOREViewers praise “brilliant” Billy Connolly charity video
READ MOREThis month’s Parkinson’s stories from around the globe
READ MORE
Comments